What is the prevalence of Mal de debarquement?

TL;DR: The exact prevalence of Mal de debarquement syndrome (MdDS) remains unknown due to frequent underdiagnosis and lack of standardized reporting, though it is clinically classified as a rare vestibular disorder. While population-wide data is limited, clinical research indicates a significant gender disparity, with females representing approximately 80% to 90% of diagnosed cases.

Is Mal de debarquement considered a rare disease?

Mal de debarquement syndrome is recognized by medical experts as a rare and often debilitating neurological condition characterized by a persistent sensation of rocking, swaying, or bobbing. Because the condition is frequently misdiagnosed as Meniere’s disease, vestibular migraine, or chronic subjective dizziness, there is no verified global prevalence rate. The lack of a diagnostic biomarker means that many individuals remain undiagnosed for years. Within the DiseaseMaps.org community, 11 individuals have connected to share their experiences with Mal de debarquement, highlighting the isolation often felt by those living with this rare condition.

How does gender and age impact Mal de debarquement incidence?

Clinical literature suggests a striking demographic skew for Mal de debarquement. Research consistently shows that women are significantly more likely to develop the disorder than men, particularly in the age range of 30 to 60 years. While the exact physiological reason for this gender bias is still being studied, researchers are investigating the potential role of hormonal fluctuations and their interaction with the vestibular system. Pediatric cases of Mal de debarquement are documented but remain substantially less common than adult-onset cases, which are typically triggered by passive motion exposure, such as cruises, flights, or even prolonged car travel.

What challenges exist in gathering accurate statistics?

Determining the true incidence of Mal de debarquement is complicated by several factors that hinder epidemiological tracking:

• Diagnostic Delay: Patients often consult multiple specialists—including ENTs, neurologists, and psychiatrists—before receiving a correct diagnosis.


• Lack of ICD Codes: Historically, the absence of a specific diagnostic code in medical billing systems has made it difficult to extract reliable prevalence data from electronic health records.


• Spontaneous Resolution: Some individuals may experience a mild or transient form of Mal de debarquement that resolves without clinical intervention, leading them to never seek medical help and thus remain uncounted in clinical statistics.


• Symptom Overlap: The symptoms of Mal de debarquement closely mimic other vestibular disorders, leading to frequent misclassification in clinical datasets.

Are there geographic or ethnic variations in the condition?

Currently, there is no evidence to suggest that Mal de debarquement is tied to specific geographic locations, ethnicities, or socio-economic backgrounds. Because the condition is often triggered by exposure to passive motion—such as travel—it is a global phenomenon. However, because specialized vestibular clinics are more prevalent in certain high-income regions, data collection is currently biased toward countries with robust neuro-otological research infrastructure, which may falsely imply higher rates in those regions.

Next steps

• Consult with a neuro-otologist or a vestibular physical therapist who specializes in Mal de debarquement.


• Maintain a symptom diary to track potential triggers and the duration of your episodes to assist your clinician.


• Connect with the DiseaseMaps.org community to share your journey and learn from others navigating the same diagnosis.


• Review current clinical trials on platforms like ClinicalTrials.gov to see if any research regarding vestibular rehabilitation or pharmacological treatments is enrolling near you.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Mal de debarquement syndrome.


• Orphanet (ORPHA: 329384): Mal de debarquement syndrome.


• Cha, Y. H. (2015). Mal de debarquement syndrome: New insights. Annals of the New York Academy of Sciences.


• Brown, J. J., & Baloh, R. W. (1987). Persistent mal de debarquement syndrome: A motion-precipitated disequilibrium syndrome. American Journal of Otolaryngology.